Table of Contents Author Guidelines Submit a Manuscript
International Journal of Surgical Oncology
Volume 2011, Article ID 468698, 10 pages
http://dx.doi.org/10.1155/2011/468698
Clinical Study

Gastrointestinal Complications in 147 Consecutive Patients with Peritoneal Surface Malignancy Treated by Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy

1Washington Cancer Institute, Washington Hospital Center, Washington, DC 20010, USA
2General Surgery and Gastroenterology Department, Reina Sofia University Hospital, Avenida Menéndez Pidal s/n., 14004 Córdoba, Spain
3Westat, Rockville, MD 20850-3129, USA

Received 3 June 2011; Accepted 13 August 2011

Academic Editor: Theodore D. Liakakos

Copyright © 2011 Angela Casado-Adam et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. H. Mahteme, L. Påhlman, B. Glimelius, and W. Graf, “Prognosis after surgery in patients with incurable rectal cancer: a population-based study,” The British Journal of Surgery, vol. 83, no. 8, pp. 1116–1120, 1996. View at Google Scholar · View at Scopus
  2. N. A. Shepherd, K. J. Baxter, and S. B. Love, “The prognostic importance of peritoneal involvement in colonic cancer: a prospective evaluation,” Gastroenterology, vol. 112, no. 4, pp. 1096–1102, 1997. View at Publisher · View at Google Scholar · View at Scopus
  3. B. Sadeghi, C. Arvieux, O. Glehen et al., “Peritoneal carcinomatosis from non-gynecologic malignancies: results of the EVOCAPE 1 multicentric prospective study,” Cancer, vol. 88, no. 2, pp. 358–363, 2000. View at Publisher · View at Google Scholar · View at Scopus
  4. P. H. Sugarbaker and K. A. Jablonski, “Prognostic features of 51 colorectal and 130 appendiceal cancer patients with peritoneal carcinomatosis treated by cytoreductive surgery and intraperitoneal chemotherapy,” Annals of Surgery, vol. 221, no. 2, pp. 124–132, 1995. View at Google Scholar · View at Scopus
  5. V. J. Verwaal, S. van Ruth, E. de Bree et al., “Randomized trial of cytoreduction and hyperthermic intraperitoneal chemotherapy versus systemic chemotherapy and palliative surgery in patients with peritoneal carcinomatosis of colorectal cancer,” Journal of Clinical Oncology, vol. 21, no. 20, pp. 3737–3743, 2003. View at Publisher · View at Google Scholar · View at Scopus
  6. O. Glehen, E. Cotte, V. Schreiber, A. C. Sayag-Beaujard, J. Vignal, and F. N. Gilly, “Intraperitoneal chemohyperthermia and attempted cytoreductive surgery in patients with peritoneal carcinomatosis of colorectal origin,” The British Journal of Surgery, vol. 91, no. 6, pp. 747–754, 2004. View at Publisher · View at Google Scholar · View at Scopus
  7. P. H. Sugarbaker, O. A. Stuart, and D. Yoo, “Strategies for management of the peritoneal surface component of cancer: cytoreductive surgery plus perioperative intraperitoneal chemotherapy,” Journal of Oncology Pharmacy Practice, vol. 11, no. 3, pp. 111–119, 2005. View at Publisher · View at Google Scholar
  8. A. Gómez Portilla, P. Barrios, S. Rufian et al., “Management of peritoneal surface malignancy with cytoreductive surgery and perioperative intraperitoneal chemotherapy,” European Journal of Surgical Oncology, vol. 32, no. 6, pp. 628–631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. D. Elias, J. H. Lefevre, J. Chevalier et al., “Complete cytoreductive surgery plus intraperitoneal chemohyperthermia with oxaliplatin for peritoneal carcinomatosis of colorectal origin,” Journal of Clinical Oncology, vol. 27, no. 5, pp. 681–685, 2009. View at Publisher · View at Google Scholar · View at Scopus
  10. C. Cao, T. D. Yan, D. Black, and D. L. Morris, “A systematic review and meta-analysis of cytoreductive surgery with perioperative intraperitoneal chemotherapy for peritoneal carcinomatosis of colorectal origin,” Annals of Surgical Oncology, vol. 16, no. 8, pp. 2152–2165, 2009. View at Publisher · View at Google Scholar · View at Scopus
  11. F. C. Muñoz-Casares, S. Rufián, M. J. Rubio et al., “The role of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) in the treatment of peritoneal carcinomatosis in recurrent ovarian cancer,” Clinical and Translational Oncology, vol. 11, no. 11, pp. 753–759, 2009. View at Publisher · View at Google Scholar
  12. T. D. Yan, L. Welch, D. Black, and P. H. Sugarbaker, “A systematic review on the efficacy of cytoreductive surgery combined with perioperative intraperitoneal chemotherapy for diffuse malignancy peritoneal mesothelioma,” Annals of Oncology, vol. 18, no. 5, pp. 827–834, 2007. View at Publisher · View at Google Scholar · View at Scopus
  13. L. Bijelic, A. Jonson, and P. H. Sugarbaker, “Systematic review of cytoreductive surgery and heated intraoperative intraperitoneal chemotherapy for treatment of peritoneal carcinomatosis in primary and recurrent ovarian cancer,” Annals of Oncology, vol. 18, no. 12, pp. 1943–1950, 2007. View at Publisher · View at Google Scholar · View at Scopus
  14. C. W. Helm, S. D. Richard, J. Pan et al., “Hyperthermic intraperitoneal chemotherapy in ovarian cancer: first report of the HYPER-O registry,” International Journal of Gynecological Cancer, vol. 20, no. 1, pp. 61–69, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. O. Glehen, F. N. Gilly, C. Arvieux et al., “Peritoneal carcinomatosis from gastric cancer: a multi-institutional study of 159 patients treated by cytoreductive surgery combined with perioperative intraperitoneal chemotherapy,” Annals of Surgical Oncology, vol. 17, no. 9, pp. 2370–2377, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. P. H. Sugarbaker, W. Yu, and Y. Yonemura, “Gastrectomy, peritonectomy and perioperative intraperitoneal chemotherapy: the evolution of treatment strategies for advanced gastric cancer,” Seminars in Surgical Oncology, vol. 21, no. 4, pp. 233–248, 2003. View at Publisher · View at Google Scholar · View at Scopus
  17. D. Baratti, S. Kusamura, A. D. Cabras, B. Laterza, M. R. Balestra, and M. Deraco, “Lymph node metastases in diffuse malignant peritoneal mesothelioma,” Annals of Surgical Oncology, vol. 17, no. 1, pp. 45–53, 2010. View at Publisher · View at Google Scholar · View at Scopus
  18. P. H. Sugarbaker, “Five reasons why cytoreductive surgery plus hyperthermic intraperitoneal chemotherapy must be regarded as the new standard of care for diffuse malignant peritoneal mesothelioma,” Annals of Surgical Oncology, vol. 17, no. 6, pp. 1710–1712, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. T. C. Chua, T. D. Yan, A. Saxena, and D. L. Morris, “Should the treatment of peritoneal carcinomatosis by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy still be regarded as a highly morbid procedure? A systematic review of morbidity and mortality,” Annals of Surgery, vol. 249, no. 6, pp. 900–907, 2009. View at Publisher · View at Google Scholar · View at Scopus
  20. B. J. Moran, “Decision-making and technical factors account for the learning curve in complex surgery,” Journal of Public Health, vol. 28, no. 4, pp. 375–378, 2006. View at Publisher · View at Google Scholar · View at Scopus
  21. T. D. Yan, M. Links, S. Fransi et al., “Learning curve for cytoreductive surgery and perioperative intraperitoneal chemotherapy for peritoneal surface malignancy—a journey to becoming a Nationally Funded Peritonectomy Center,” Annals of Surgical Oncology, vol. 14, no. 8, pp. 2270–2280, 2007. View at Publisher · View at Google Scholar · View at Scopus
  22. R. M. Smeenk, V. J. Verwaal, and F. A. Zoetmulder, “Learning curve of combined modality treatment in peritoneal surface disease,” The British Journal of Surgery, vol. 94, no. 11, pp. 1408–1414, 2007. View at Publisher · View at Google Scholar · View at Scopus
  23. O. Glehen, D. Osinsky, E. Cotte et al., “Intraperitoneal chemohyperthermia using a closed abdominal procedure and cytoreductive surgery for the treatment of peritoneal carcinomatosis: morbidity and mortality analysis of 216 consecutive procedures,” Annals of Surgical Oncology, vol. 10, no. 8, pp. 863–869, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. S. Kusamura, R. Younan, D. Baratti et al., “Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion. Analysis of morbidity and mortality in 209 peritoneal surface malignancies treated with closed abdomen technique,” Cancer, vol. 106, no. 5, pp. 1144–1153, 2006. View at Publisher · View at Google Scholar · View at Scopus
  25. J. Hansson, W. Graf, L. Påhlman, P. Nygren, and H. Mahteme, “Postoperative adverse events and long-term survival after cytoreductive surgery and intraperitoneal chemotherapy,” European Journal of Surgical Oncology, vol. 35, no. 2, pp. 202–208, 2009. View at Publisher · View at Google Scholar · View at Scopus
  26. H. Youssef, C. Newman, K. Chandrakumaran, F. Mohamed, T. D. Cecil, and B. J. Moran, “Operative findings, early complications, and long-term survival in 456 patients with pseudomyxoma peritonei syndrome of appendiceal origin,” Diseases of the Colon and Rectum, vol. 54, no. 3, pp. 293–299, 2011. View at Publisher · View at Google Scholar
  27. R. Younan, S. Kusamura, D. Baratti et al., “Bowel complications in 203 cases of peritoneal surface malignancies treated with peritonectomy and closed-technique intraperitoneal hyperthermic perfusion,” Annals of Surgical Oncology, vol. 12, no. 11, pp. 910–918, 2005. View at Publisher · View at Google Scholar · View at Scopus
  28. P. Jacquet and P. H. Sugarbaker, “Current methodologies for clinical assessment of patients with peritoneal carcinomatosis,” Journal of Experimental and Clinical Cancer Research, vol. 15, no. 1, pp. 49–58, 1996. View at Google Scholar · View at Scopus
  29. P. H. Sugarbaker, A. M. Averbach, P. Jacquet, A. D. Stephens, and O. A. Stuart, “A simplified approach to hyperthermic intraoperative intraperitoneal chemotherapy (HIIC) using a self retaining retractor,” in Peritoneal Carcinomatosis: Principles of Management, P. H. Sugarbaker, Ed., pp. 415–421, Kluwer Academic, Boston, Mass, USA, 1996. View at Google Scholar
  30. NCI DHHS DTCD, Common Terminology Criteria for adverse events v3.0 (CTAE), Cancer Therapy Evaluation Program, 2006.
  31. P. H. Sugarbaker, “It's what the surgeon doesn't see that kills the patient,” Journal of Nippon Medical School, vol. 67, no. 1, pp. 5–8, 2000. View at Google Scholar · View at Scopus
  32. K. Van der Speeten, O. A. Stuart, and P. H. Sugarbaker, “Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancy,” Cancer Journal, vol. 15, no. 3, pp. 216–224, 2009. View at Publisher · View at Google Scholar · View at Scopus